1. Home
  2. WEN vs PGEN Comparison

WEN vs PGEN Comparison

Compare WEN & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wendy's Company (The)

WEN

Wendy's Company (The)

HOLD

Current Price

$6.63

Market Cap

1.4B

ML Signal

HOLD

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$4.30

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEN
PGEN
Founded
1969
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2000
2013

Fundamental Metrics

Financial Performance
Metric
WEN
PGEN
Price
$6.63
$4.30
Analyst Decision
Hold
Buy
Analyst Count
22
5
Target Price
$8.84
$8.33
AVG Volume (30 Days)
7.1M
2.7M
Earning Date
05-08-2026
05-13-2026
Dividend Yield
8.28%
N/A
EPS Growth
N/A
N/A
EPS
0.85
N/A
Revenue
$2,176,891,000.00
$230,981,000.00
Revenue This Year
$2.26
$1,115.92
Revenue Next Year
$0.94
$81.04
P/E Ratio
$7.69
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.52
$1.23
52 Week High
$12.52
$5.47

Technical Indicators

Market Signals
Indicator
WEN
PGEN
Relative Strength Index (RSI) 41.51 60.72
Support Level N/A $3.91
Resistance Level $7.28 $4.40
Average True Range (ATR) 0.24 0.20
MACD -0.02 0.01
Stochastic Oscillator 30.00 85.12

Price Performance

Historical Comparison
WEN
PGEN

About WEN Wendy's Company (The)

The Wendy's Co is engaged in operating, developing, and franchising a system of distinctive quick-service restaurants serving high-quality food. The company operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development. Wendy's U.S. and Wendy's International include the operation and franchising of restaurants and derive revenues from sales at company-operated restaurants, as well as royalties, franchise fees, and advertising fund collections from franchised restaurants. Global Real Estate & Development includes real estate activities for owned and leased sites that are leased or subleased to franchisees and includes the company's share of income from its Canadian restaurant real estate joint venture.

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

Share on Social Networks: